Sharon Puthli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sharon Puthli has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Jakob Reiser
Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, MD 20993, USA
1 shared publication - Michael P Marino
Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, Maryland 20892, USA
1 shared publication - Robert Kutner
Gene Therapy Program, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2009
- Published by Springer Nature in BMC Biotechnology
- Vol. 9 (1) , 10
Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography
During the past twelve years, lentiviral (LV) vectors have emerged as valuable tools for transgene delivery because of their ability to transduce nondividing cells and their capacity to sustain long-term transgene expression in target cells in vitro and in vivo. However, despite significant progress, the production and concentration of high-titer, high-quality LV vector stocks is still cumbersome and costly.
- 1 January 2009
- Published by Springer Nature in BMC Biotechnology
- Vol. 9 (1) , 10
Open AccessSimplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography
During the past twelve years, lentiviral (LV) vectors have emerged as valuable tools for transgene delivery because of their ability to transduce nondividing cells and their capacity to sustain long-term transgene expression in target cells in vitro and in vivo. However, despite significant progress, the production and concentration of high-titer, high-quality LV vector stocks is still cumbersome and costly.